Atherosclerosis and inflammation;Athérosclérose et inflammation

Medecine/Sciences

Volumn 17, Issue 2, 2001, Pages 162-169

  Tedgui, A ^a   Mallat, Z ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY INTIMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; CORONARY RISK; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; LYMPHOCYTE; MONOCYTE; REVIEW; SHEAR STRESS; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

THROMBUS;

EID: 17444438957     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1888     Document Type: Review

References (49)

1. The pathogenesis of atherosclerosis
2. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: Cholesterol acyltransferase gene. Evidence for expression in brain and testis as well as liver
3. Endothelium modifies the altered metabolism of the injured aortic wall
4. Is vascular smooth muscle cell proliferation beneficial?
5. Stability and instability: Two faces of coronary atherosclerosis
6. Atherosclerosis-an inflammatory disease
7. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
8. Oxidative modification of LDL and atherogenesis
9. The oxidative modification hypothesis of atherogenesis: An overview
10. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms
11. Role of oxidized low density lipoprotein in atherogenesis
12. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety
13. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation
14. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
15. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice
16. Ath-1 a gene determining atherosclerosis susceptibility and high density lipoprotein level in mice
17. MCP1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
18. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
19. Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis
20. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
21. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
22. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice
23. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
24. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells
25. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
26. IFN-gamma potentiates atherosclerosis in apoE knock-out mice
27. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
28. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
29. Anti-inflammatory cytokines
30. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
31. Expression of interleukin-10 in human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death
32. Protective role of interleukin-10 in atherosclerosis
33. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
34. Immunology of atherosclerosis - Demonstration of heat shock protein-60 expression and T-lymphocytes bearing α/β or γ/δ receptor in human atherosclerotic lesions
35. Lymphocytes-T in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1
36. Requirement for CD154 in the progression of atherosclerosis
37. Apoptosis in the vasculature: Mechanisms and functional importance
38. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques
39. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta
40. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway: Prevention by aurintricarboxylic acid
41. Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol
42. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
43. The identification of active tissue factor in human coronary atheroma
44. Acute coronary syndromes: Biology
45. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (αvβ3)
46. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection
47. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
48. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway
49. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men